Antimicrobial susceptibility of clinical Campylobacter isolates collected at a German university hospital during the period 2006–2008

Abstract

A total of 113 clinical Campylobacter strains (105 C. jejuni, 7 C. coli, 1 C. lari) were collected between 2006 and 2008 and tested for antimicrobial susceptibility to erythromycin, ciprofloxacin, doxycycline and meropenem. Of all the Campylobacter isolates, 52.2% were resistant to ciprofloxacin and 38.0% to doxycycline. None of them was resistant to erythromycin or meropenem. However, 51.3% of all Campylobacter isolates were intermediate susceptible to erythromycin (minimum inhibitory concentration 1–4 mg/l). These data confirm the value of macrolides as the drugs of choice for the treatment of severe Campylobacter infections.

Acknowledgements

We are grateful to Daniela Müller and Monika Panke for expert technical assistance and to Thien-Tri Lam and Dennis Tappe for their assistance in editing the manuscript.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.